An upregulated CD94 expression on NK cells has been shown to correlate with an elevated cytolytic activity against mHsp70+ tumor cells in vitro and in clinical trials (Multhoff et al., 1999; Krause et al., 2004; Kokowski et al., 2019; Multhoff et al., 2020). The gene discussed is KLRD1; the disease is neoplasm.